面部血管化复合组织移植排斥反应与实验室标志物的相关性:八例患者回顾性研究的启示
该回顾性研究分析了8例患者共9次面部血管化复合组织移植的标准实验室指标与排斥反应的关系,采用线性混合模型处理纵向重复测量数据。结果发现Banff排斥分级与嗜碱性粒细胞相对数量显著相关(p=0.005),临床排斥征象且皮肤活检Banff≥II时CRP显著升高(p=0.03),而白细胞计数在排斥期间保持稳定,中性粒细胞相对数量较低。结论认为多数标准实验室参数和生命体征在排斥期间稳定,白细胞增多可能用于提示微生物感染而非排斥。
要点
- Banff排斥分级与嗜碱性粒细胞相对数量显著相关(p=0.005)。
- 临床排斥征象且皮肤活检Banff≥II时CRP显著升高(p=0.03)。
- 排斥期间白细胞计数稳定,中性粒细胞相对数量较低。
核心结论
- 面部血管化复合组织移植排斥期间,大多数标准实验室参数和生命体征似乎保持稳定。
- 排斥期间CRP和嗜碱性粒细胞水平升高,而中性粒细胞计数较低。
- 白细胞增多可能可作为面部血管化复合组织移植患者微生物感染的标志物,因为白细胞计数在同种异体移植排斥时似乎不升高。
研究设计与样本
- 回顾性研究,复习8例面部血管化复合组织移植患者共9次移植的医疗记录。
- 提取标准实验室值(全血细胞计数、基础代谢面板、肝功能检查、C反应蛋白)和生命体征数据。
- 采用线性混合模型分析实验室值与排斥状态的关系,考虑数据的纵向重复测量性质。
主要发现
- 排斥期间Banff排斥分级与患者血液中嗜碱性粒细胞相对数量之间存在统计学显著关系(p=0.005)。
- 在具有临床排斥征象(如面部红斑、水肿)且皮肤活检显示Banff≥II的患者中,CRP显著升高(p=0.03)。
- 排斥期间白细胞计数保持稳定,中性粒细胞相对数量在排斥时较低,提示可能在排斥部位消耗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The field of facial vascularized composite allotransplantation (fVCA) is still new and a limited number of patients have undergone the procedure. This has led to a lack of understanding about the impact of fVCA rejection on standard laboratory markers (e.g., CBC, BMP, CRP) for the acute management of these patients. It is not clear if rejection elicits a systemic inflammatory response that influences common inflammatory markers such as WBC and CRP. A comprehensive understanding of changes in these markers could help in the management of fVCA patients in the acute setting. METHODS: The medical records of 8 fVCA patients with a total of 9 transplants were reviewed retrospectively, and data on standard laboratory values (CBC, BMP, LFTs, CRP) and vital signs were extracted. To examine the relationship between laboratory values and rejection status, linear mixed models were used to analyze the data, taking into account their longitudinal nature (repeated measures). RESULTS: A statistically significant relationship was found between the Banff grade of rejection and the relative number of basophils in the patient's blood during rejection (p = 0.005). In addition, in patients with clinical signs of rejection (e.g., facial erythema, edema) and skin biopsy showing Banff ≥ II, CRP was found to be significantly elevated (p = 0.03). The WBC count remained stable during rejection, and the relative number of neutrophils was lower at the time of rejection, indicating possible consumption at the site of rejection. CONCLUSION: During fVCA rejection, most standard laboratory parameters and vital signs appear to be stable. However, the levels of CRP and basophils were elevated during rejection, while the neutrophil count was lower. Leukocytosis can likely be used as a marker of microbial infection in fVCA patients, as WBC does not seem to increase at the time of allograft rejection.
引用
- Kauke-Navarro M, Knoedler S, Panayi AC, et al. Correlation between facial vascularized composite allotransplantation rejection and laboratory markers: Insights from a retrospective study of eight patients. J Plast Reconstr Aesthet Surg. 2023. PMID: 37276734. doi:10.1016/j.bjps.2023.04.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。